美迪西(688202) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥355,988,685.97, representing a year-over-year increase of 65.79%[7] - Net profit attributable to shareholders for Q1 2022 was ¥77,191,634.76, reflecting a growth of 71.09% compared to the same period last year[7] - Basic earnings per share for Q1 2022 were ¥1.24, up 69.86% from the previous year[7] - Total revenue for Q1 2022 reached ¥355,988,685.97, a significant increase of 65.8% compared to ¥214,726,795.49 in Q1 2021[32] - Net profit for Q1 2022 was ¥77,191,634.76, compared to ¥47,403,100.16 in Q1 2021, representing a growth of 62.9%[36] - The total comprehensive income attributable to the parent company owners for the current period is 77,191,634.76, compared to 45,118,700.74 in the previous period, indicating strong overall performance[38] Cash Flow and Investments - The net cash flow from operating activities was -¥50,973,115.14, a decline of 328.82% year-over-year, primarily due to increased payments for experimental animals and slower customer payments[7][15] - Cash inflow from operating activities totaled 271,911,405.00, compared to 192,131,224.75 in the previous period, reflecting a growth of approximately 41.5%[43] - The net cash flow from operating activities decreased to -50,973,115.14 from 22,276,276.28 in the previous period, indicating a shift to negative cash flow[43] - Cash outflow from investing activities was 256,481,733.48, compared to 75,808,870.78 in the previous period, showing a substantial increase in investment expenditures[44] - The net cash flow from investing activities was -151,229,082.73, indicating a significant increase in cash used for investments compared to the previous period[44] - The cash and cash equivalents at the end of the period decreased to 204,839,450.81 from 408,281,006.51 in the previous period, reflecting a decline of approximately 50%[44] Assets and Liabilities - Total assets at the end of Q1 2022 amounted to ¥1,872,150,004.15, an increase of 4.38% from the end of the previous year[10] - Non-current assets totaled ¥956,287,302.74, an increase from ¥901,535,141.35 in the previous period[30] - Current liabilities remained stable at ¥383,956,446.71, slightly up from ¥383,662,450.66[30] - Deferred income tax liabilities increased to ¥25,496,054.84 from ¥22,162,759.89, marking a rise of 15.4%[32] - The company's fixed assets increased to CNY 438,272,262.22 from CNY 410,559,535.62, marking an increase of approximately 6.7%[27] Research and Development - R&D investment totaled ¥23,419,279.52, which is a 52.49% increase year-over-year, indicating a focus on enhancing R&D capabilities[10][15] - The proportion of R&D investment to revenue was 6.58%, a decrease of 0.57 percentage points compared to the previous year[10] - Research and development expenses for Q1 2022 were ¥23,419,279.52, compared to ¥15,358,165.05 in Q1 2021, reflecting a 52.5% increase[36] - The company plans to continue enhancing its R&D service capabilities and expanding its laboratory capacity to support future growth[15] Shareholder Information - The company plans to issue A-shares to specific investors as approved in meetings held on February 10 and February 28, 2022, to enhance capital for future growth[24] - The total number of shares held by the top ten unrestricted shareholders amounts to 12,000,000 shares, with the largest shareholder holding 3,034,138 shares[20] - The company has established a consistent action relationship among key shareholders, which may influence strategic decisions moving forward[23] Market and Growth Strategy - The company signed a significant number of new orders, driven by increasing recognition of its R&D service capabilities[12] - The company is actively pursuing market expansion and new product development strategies as part of its growth initiatives[24] - The company's accounts receivable increased to CNY 285,173,457.53 from CNY 212,503,512.34, reflecting a growth of about 34.2% year-over-year[27] - Inventory levels rose to CNY 139,081,069.83, up from CNY 83,479,898.47, indicating an increase of approximately 66.7% compared to the previous year[27] - The company reported a significant increase in prepayments, which rose to CNY 65,046,571.03 from CNY 36,553,409.61, reflecting an increase of approximately 78.2%[27]